If it meant prolonging the company (and my income) or if it helped stem the share price so the next capital raise is less dilutive then yes.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025